Suppr超能文献

Author Correction: Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial.

作者信息

Brown Christine E, Hibbard Jonathan C, Alizadeh Darya, Blanchard M Suzette, Natri Heini M, Wang Dongrui, Ostberg Julie R, Aguilar Brenda, Wagner Jamie R, Paul Jinny A, Starr Renate, Wong Robyn A, Chen Wuyang, Shulkin Noah, Aftabizadeh Maryam, Filippov Aleksandr, Chaudhry Ammar, Ressler Julie A, Kilpatrick Julie, Myers-McNamara Paige, Chen Mike, Wang Leo D, Rockne Russell C, Georges Joseph, Portnow Jana, Barish Michael E, D'Apuzzo Massimo, Banovich Nicholas E, Forman Stephen J, Badie Behnam

机构信息

Department of Hematology & Hematopoietic Cell Transplantation (T Cell Therapeutics Research Laboratories), City of Hope Beckman Research Institute and Medical Center, Duarte, CA, USA.

Department of Computational and Quantitative Medicine, City of Hope Beckman Research Institute and Medical Center, Duarte, CA, USA.

出版信息

Nat Med. 2024 May;30(5):1501. doi: 10.1038/s41591-024-02928-5.

DOI:10.1038/s41591-024-02928-5
PMID:38514871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11108767/
Abstract
摘要

相似文献

1
Author Correction: Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial.作者更正：靶向IL-13Rα2的嵌合抗原受体T细胞在复发性高级别胶质瘤中的局部递送：一项1期试验。
Nat Med. 2024 May;30(5):1501. doi: 10.1038/s41591-024-02928-5.
2
Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo.在体外和体内鉴定和表征针对 IL13Rα2 阳性人神经胶质瘤的新型 CAR-T 细胞。
Clin Transl Med. 2024 May;14(5):e1664. doi: 10.1002/ctm2.1664.
3
Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with Zirconium oxine for PET imaging.放射性核素标记奥昔美辛标记嵌合抗原受体修饰的 T 细胞用于 PET 成像后 scFv-IL-13Rα2 的鉴定。
J Transl Med. 2023 Jun 7;21(1):367. doi: 10.1186/s12967-023-04142-2.
4
Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.源自白细胞介素-13受体α2链（一种胶质瘤相关抗原）的人白细胞抗原-A24限制性T细胞表位的鉴定
J Neurosurg. 2008 Jul;109(1):117-22. doi: 10.3171/JNS/2008/109/7/0117.
5
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma.白细胞介素-13受体α2状态预测GB-13（IL13.E13K-PE4E）在高级别胶质瘤中的疗效。
Pharmaceutics. 2022 Apr 24;14(5):922. doi: 10.3390/pharmaceutics14050922.
6
Expression of IL-13Rα2 and FUS in glioma: clinicopathological and prognostic correlation.IL-13Rα2 和 FUS 在脑胶质瘤中的表达：临床病理和预后相关性。
BMC Neurol. 2023 May 8;23(1):185. doi: 10.1186/s12883-023-03237-z.
7
IL-13Rα2-targeted CAR T cells show promise in patients with recurrent high-grade gliomas.靶向白细胞介素-13受体α2的嵌合抗原受体T细胞在复发性高级别胶质瘤患者中显示出前景。
Nat Rev Clin Oncol. 2024 May;21(5):335. doi: 10.1038/s41571-024-00885-z.
8
Gastrodin synergistically increases migration of interleukin-13 receptor α2 chimeric antigen receptor T cell to the brain against glioblastoma multiforme: A preclinical study.天麻素协同增强白细胞介素-13受体α2嵌合抗原受体T细胞向脑内迁移以对抗多形性胶质母细胞瘤：一项临床前研究。
Phytother Res. 2023 Dec;37(12):5947-5957. doi: 10.1002/ptr.8007. Epub 2023 Sep 25.
9
Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma.在高级别弥漫浸润性小儿脑干胶质瘤中原位鉴定白细胞介素-13受体α2链过表达。
Neuro Oncol. 2008 Jun;10(3):265-74. doi: 10.1215/15228517-2007-066. Epub 2008 Apr 22.
10
Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.白细胞介素-13在癌症、肺纤维化及其他2型辅助性T细胞（TH2）相关疾病中的作用。
Vitam Horm. 2006;74:479-504. doi: 10.1016/S0083-6729(06)74019-5.

引用本文的文献

1
CAR-T cell therapy for glioblastoma: advances, challenges, and future directions.胶质母细胞瘤的嵌合抗原受体T细胞疗法：进展、挑战与未来方向
Ann Med Surg (Lond). 2025 Jul 18;87(9):5743-5756. doi: 10.1097/MS9.0000000000003607. eCollection 2025 Sep.
2
IL-13Rα2-targeted CAR T cells show promise in patients with recurrent high-grade gliomas.靶向白细胞介素-13受体α2的嵌合抗原受体T细胞在复发性高级别胶质瘤患者中显示出前景。
Nat Rev Clin Oncol. 2024 May;21(5):335. doi: 10.1038/s41571-024-00885-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验